AstraZeneca

ASCO 2023 – early first-line lung cancer data mined for datopotamab gold
EP Vantage
Wed, 06/7/23 - 10:02 am
ASCO 2023
Daiichi Sankyo
AstraZeneca
datopotamab deruxtecan
non-small cell lung cancer
ASCO 2023: AstraZeneca’s PD-1/TIGIT shows promise in checkpoint-exposed NSCLC
Clinical Trials Arena
Tue, 06/6/23 - 10:06 am
ASCO 2023
AstraZeneca
clinical trials
non-small cell lung cancer
rilvegostomig
ASCO: AstraZeneca Posts Strong Survival Data for Tagrisso in NSCLC Patients
BioSpace
Mon, 06/5/23 - 09:59 pm
ASCO 2023
AstraZeneca
Tagrisso
non-small cell lung cancer
AZ notches postmarket win for bleeding reversal agent Andexxa, plans to seek full approval
Fierce Pharma
Mon, 06/5/23 - 09:55 pm
AstraZeneca
bleeding reversal
AndexXa
AstraZeneca study points to new uses for targeted cancer drug Enhertu
BioPharma Dive
Mon, 06/5/23 - 11:32 am
ASCO 2023
AstraZeneca
Enhertu
uterine cancer
cervical cancer
ovarian cancer
bladder cancer
ASCO: AstraZeneca guns for wider ovarian cancer market with Imfinzi-Lynparza combo. Will the FDA buy the plan?
Fierce Pharma
Sun, 06/4/23 - 04:24 pm
ASCO 2023
AstraZeneca
Lynparza
Imfinzi
ovarian cancer
FDA clears narrow use of Lynparza in prostate cancer, continuing ‘shift’ on PARP drugs
BioPharma Dive
Thu, 06/1/23 - 11:53 am
AstraZeneca
Merck
Lynparza
prostate cancer
FDA
Liberate Bio taps former AZ drug-delivery head for CEO post
Medical Marketing and Media
Thu, 06/1/23 - 11:45 am
Liberate Bio
Pharma CEOs
AstraZeneca
Shawn Davis
AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral
Fierce Biotech
Thu, 06/1/23 - 11:41 am
AstraZeneca
IBD
AbbVie
JNJ
brazikumab
Skyrizi
Stelara
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
AstraZeneca reports positive results from endometrial cancer therapy trial
Clinical Trials Arena
Mon, 05/29/23 - 12:24 pm
AstraZeneca
endometrial cancer
clinical trials
Imfinzi
Lynparza
AstraZeneca's drug combo shows positive results in late-stage cancer trial
Reuters
Fri, 05/26/23 - 10:09 am
ASCO 2023
AstraZeneca
Imfinzi
Lynparza
endometrial cancer
AstraZeneca Deepens Gene Editing Capabilities with Revvity Partnership
BioSpace
Thu, 05/18/23 - 11:21 am
AstraZeneca
Revvity
gene editing
cell therapy
AstraZeneca's Tagrisso, chemo combination shows promise in lung cancer trial
Yahoo/Reuters
Wed, 05/17/23 - 11:16 am
AstraZeneca
clinical trials
Tagrisso
AstraZeneca is third member to leave PhRMA in five months
Stat
Tue, 05/16/23 - 12:03 pm
AstraZeneca
lobbying
PhRMA
AstraZeneca Expands ADC Portfolio with $600M Deal with LaNova
BioSpace
Mon, 05/15/23 - 06:35 pm
AstraZeneca
antibody-drug conjugate
LaNova Medicines
The waxing and waning of the speedy approval
EP Vantage
Mon, 05/15/23 - 09:58 am
FDA
drug approvals
accelerated approvals
AbbVie
AstraZeneca
Bayer
Bristol Myers Squibb
JNJ
Merck
Merck KGaA
Novartis
Pfizer
Farxiga’s approval for expanded use highlights potential to differentiate in HF space
Clinical Trials Arena
Fri, 05/12/23 - 11:42 am
AstraZeneca
Farxiga
heart failure
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
drug launches
AbbVie
Almirall
Apellis Pharmaceuticals
Astellas
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eli Lilly
Genmab
GSK
Iveric Bio
Pfizer
Roche
SAGE Therapeutics
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Vertex Pharmaceuticals
Sanofi, AstraZeneca Report Promising RSV Pediatric Data Ahead of Pfizer Adcomm
BioSpace
Fri, 05/12/23 - 10:16 am
Sanofi
AstraZeneca
RSV
antibodies
infants
clinical trials

Pages